This study is the first to identify HIF-1α as a modulator of PII-driven aromatase expression in human breast tumor-associated stroma and provides a novel mechanism for estrogen regulation in obesity-related, post-menopausal breast cancer. This evidence concerns the gene HIF1A and obesity due to melanocortin 4 receptor deficiency.